Biointron

Biointron,founded in 2012, is an award-winning Chinese National High-tech Enterprise.We specialize in antibody expression,discovery,and optimization.Our mission is to accelerate the antibody discovery process to provide one-stop antibody discovery services.With fully automated production processes adhering to international standards,we've served 1,500*pharmaceutical companies across more than 20 countries.Our expertise includes VHH production, hybridoma sequencing, antibody humanization,affinity maturation,and single B cell screening. Biointron has global commercialization reauthorization for ECACC's CHO-K1 cell line and meets international multicenter requirements, which has also been filed with the U.S. FDA's DMF and several partners' projects have entered the international multicenter clinical stage. 

For more information,please visit our official website at www.biointron. com or contact us at info@biointron.com. 

Visit us on booth 7